Serum KL-6 in fibrotic NSIP: Correlations with physiologic and radiologic parameters

Respiratory Medicine

Volumn 104, Issue 1, 2010, Pages 127-133

  Sakamoto, Koji ^a   Taniguchi, Hiroyuki ^b   Kondoh, Yasuhiro ^b   Johkoh, Takeshi ^c   Sumikawa, Hiromitsu ^d   Kimura, Tomoki ^b   Nishiyama, Osamu ^b   Kato, Keisuke ^b   Kataoka, Kensuke ^b   Ono, Kenzo ^b   Kitaichi, Mansanori ^e   Hasegawa, Yoshinori ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOSEI GENERAL HOSPITAL   (Japan)

^c Kinki Central Hospital   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

Author keywords

High resolution computed tomography; KL 6; MUC1 protein; Nonspecific interstitial pneumonia; Pulmonary fibrosis; Serum marker

Indexed keywords

BIOLOGICAL MARKER; KL 6 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPNEA; FEMALE; FIBROTIC NONSPECIFIC INTERSTITIAL PNEUMONIA; HUMAN; LUNG BIOPSY; LUNG DISEASE; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; PRIORITY JOURNAL; VITAL CAPACITY;

ADULT; AGED; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUCIN-1; PROGNOSIS; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 73849132550     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.08.011     Document Type: Article

References (27)

1. Katzenstein A.L., and Fiorelli R.F. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 18 (1994) 136-147
2. Cottin V., Donsbeck A.V., Revel D., Loire R., and Cordier J.F. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 158 (1998) 1286-1293
3. Travis W.D., Hunninghake G., King Jr. T.E., Lynch D.A., Colby T.V., Galvin J.R., et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 177 (2008) 1338-1347
4. Kohno N., Kyoizumi S., Awaya Y., Fukuhara H., Yamakido M., and Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 96 (1989) 68-73
5. Yamane K., Ihn H., Kubo M., Yazawa N., Kikuchi K., Soma Y., et al. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. J Rheumatol 27 (2000) 930-934
6. Kohno N., Hamada H., Fujioka S., Hiwada K., Yamakido M., and Akiyama M. Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer. Chest 102 (1992) 117-122
7. Kobayashi J., Tsukagoshi M., Hagiwara S., Kitamura S., Hirota N., and Saito K. Hypersensitivity pneumonitis monitored with serum KL-6, a marker of interstitial pneumonia. Nihon Kyobu Shikkan Gakkai Zasshi 34 (1996) 837-842
8. Kobayashi J., and Kitamura S. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest 109 (1996) 1276-1282
9. Takahashi T., Munakata M., Suzuki I., and Kawakami Y. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 158 (1998) 1294-1298
10. Yokoyama A., Kohno N., Hamada H., Sakatani M., Ueda E., Kondo K., et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 158 (1998) 1680-1684
11. Kobayashi J., and Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest 108 (1995) 311-315
12. Kim E.A., Johkoh T., Lee K.S., Ichikado K., Koh E.M., Kim T.S., et al. Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation. J Comput Assist Tomogr 25 (2001) 757-763
13. Altman D.G. Practical statistics for medical research (1991), Champman and Hill, London
14. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165 (2002) 277-304
15. Ishii H., Mukae H., Kadota J., Kaida H., Nagata T., Abe K., et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 58 (2003) 52-57
16. Matusiewicz S.P., Williamson I.J., Sime P.J., Brown P.H., Wenham P.R., Crompton G.K., et al. Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?. Eur Respir J 6 (1993) 1282-1286
17. Kinder B.W., Collard H.R., Koth L., Daikh D.I., Wolters P.J., Elicker B., et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?. Am J Respir Crit Care Med 176 (2007) 691-697
18. Johkoh T., Muller N.L., Colby T.V., Ichikado K., Taniguchi H., Kondoh Y., et al. Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 225 (2002) 199-204
19. Sumikawa H., Johkoh T., Colby T.V., Ichikado K., Suga M., Taniguchi H., et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med 177 (2008) 433-439
20. Sahin H., Brown K.K., Curran-Everett D., Hale V., Cool C.D., Vourlekis J.S., et al. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology 244 (2007) 591-598
21. Takahashi H., Fujishima T., Koba H., Murakami S., Kurokawa K., Shibuya Y., et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 162 (2000) 1109-1114
22. Remy-Jardin M., Giraud F., Remy J., Copin M.C., Gosselin B., and Duhamel A. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology 189 (1993) 693-698
23. Janssen R., Sato H., Grutters J.C., Bernard A., van Velzen-Blad H., du Bois R.M., et al. Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis. Chest 124 (2003) 2119-2125
24. Nagai S., Kitaichi M., Itoh H., Nishimura K., Izumi T., and Colby T.V. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 12 (1998) 1010-1019
25. Veeraraghavan S., Latsi P.I., Wells A.U., Pantelidis P., Nicholson A.G., Colby T.V., et al. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J 22 (2003) 239-244
26. Nishiyama O., Taniguchi H., Kondoh Y., Kimura T., Ogawa T., Watanabe F., et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?. Respir Med 99 (2005) 408-414
27. Manali E.D., Stathopoulos G.T., Kollintza A., Kalomenidis I., Emili J.M., Sotiropoulou C., et al. The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis. Respir Med 102 (2008) 586-592